Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Antiviral Research|June 6, 2024
Identification of a macrocyclic compound targeting the lassa virus polymeraseVirginia Aida-Ficken, Jamie A Kelly, Payel Chatterjee, et al.
Antiviral Research|November 7, 2016
Lassa and Ebola virus inhibitors identified using minigenome and recombinant virus reporter systemsStephen R Welch, Lisa Wiggleton Guerrero, Ayan K Chakrabarti, et al.
Nature Communications|January 19, 2019
A genome-wide CRISPR screen identifies N-acetylglucosamine-1-phosphate transferase as a potential antiviral target for Ebola virusMike Flint, Payel Chatterjee, David L Lin, et al.
Antiviral Research|April 17, 2025
Mechanisms of action of repurposed Ebola virus antivirals - the roles of phospholipidosis and cholesterol homeostasisJamie A Kelly, Virginia Aida-Ficken, Laura K McMullan, et al.
Antiviral Research|May 20, 2015
Inhibitors of cellular kinases with broad-spectrum antiviral activity for hemorrhagic fever virusesEmma L Mohr, Laura K McMullan, Michael K Lo, et al.
Microbiology (Reading, England)|May 1, 2013
A novel approach to generate a recombinant toxoid vaccine against Clostridium difficileRobert G K Donald, Mike Flint, Narender Kalyan, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 8, 2020
Remdesivir targets a structurally analogous region of the Ebola virus and SARS-CoV-2 polymerasesMichael K Lo, César G Albariño, Jason K Perry, et al.
Scientific Reports|March 7, 2017
GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and ParamyxovirusesMichael K Lo, Robert Jordan, Aaron Arvey, et al.
Pageof 6